About Mirvie
Mirvie is a healthcare AI company dedicated to transforming pregnancy health through the early prediction of complications. Their proprietary Mirvie RNA platform utilizes a simple blood test to analyze tens of thousands of RNA messages from the mother, placenta, and baby. By applying advanced machine learning and AI to this transcriptomic data, the platform can detect the underlying biological drivers of various pregnancy complications, such as preeclampsia, preterm birth, and fetal growth restriction, months before symptoms appear.
This innovative approach aims to shift prenatal care from a reactive, crisis-management model to a proactive, preventive, and personalized one. For physicians, this means having vital, actionable information about a pregnancy’s unique biology, enabling earlier interventions and tailored care plans to improve outcomes for both mothers and babies. Mirvie’s Encompass™ test, for example, is designed to predict the risk of preeclampsia, with studies showing its ability to identify a significant percentage of women who will develop the condition months in advance.
Focus Areas
Business Intelligence
| Technology | The Mirvie RNA Platform combines advanced transcriptomic analysis of tens of thousands of RNA messages from the baby, placenta, and mother with machine learning and AI. This platform, utilizing a simple blood test, reveals vital information about a pregnancy's unique biology to predict complications months before they occur. |
What Physicians Need to Know
Mirvie's predictive tests, such as the Encompassu2122 test for preeclampsia, offer physicians the ability to identify high-risk pregnancies months in advance, enabling the implementation of evidence-based prevention care plans, such as low-dose aspirin and close clinical management. This shifts prenatal care from a reactive 'wait and see' approach to a proactive and personalized model, potentially delaying onset or preventing severe complications. The platform also provides a deeper understanding of the underlying biology of pregnancy complications, which can lead to more precise and personalized interventions.
Mirvie is actively partnering with healthcare providers and benefits providers to integrate their predictive testing into maternal health programs. For example, they have launched a pilot program with Advantia Health to improve pregnancy outcomes using the Encompass Preeclampsia Test. They are also partnering with WIN, a family-building and family wellness benefits provider, to offer the Encompass test as part of an expanded maternal health solution. These collaborations aim to facilitate early preventive care interventions and provide individualized support to pregnant women.
What the Web Says
Mirvie is a company developing a medical diagnostic platform that uses RNA sequencing and machine learning to predict pregnancy complications like preeclampsia and preterm birth months before symptoms appear. Their first commercial product, Encompass, launched in 2025 and focuses on predicting preeclampsia risk. The company aims to transform prenatal care from reactive to proactive by providing clinicians and expectant mothers with early risk assessment and personalized action plans.
Overall: PositiveStrengths
- Predicts pregnancy complications months in advance, allowing for proactive intervention.
- Utilizes advanced RNA platform and machine learning for a deeper understanding of pregnancy biology.
- Encompass test shows high probability of not developing preterm preeclampsia with a low-risk result (99.7%).
- Backed by significant clinical studies and peer-reviewed research.
- Positive employee reviews mention a great work environment, supportive management, and exciting work.
- Offers a direct-to-consumer online purchase process with telehealth clinician review and mobile phlebotomy.
Limitations
- As a startup, there's a risk of constant changes and potential layoffs.
- The underlying studies are company-sponsored, which, while peer-reviewed, is noted as a factor to consider.
- The product is sold with a virtual assistant, raising questions about automated systems conversing with pregnant women about serious conditions.
- Lack of randomized comparison against standard care means no direct evidence yet that acting on the result changes outcomes.
- Test has not yet been adopted into national guidelines.
- No breakdown of test performance by race or ethnicity, which is crucial given racial disparities in maternal mortality.
Based on reviews from: Indeed.com, AI Health Index, PitchBook, Forbes, Mirvie.com, Reddit, Business Wire, Femtech Insider
Last updated: 2026-08-24
Videos
News, demos, and interviews about Mirvie.
Videos load interactively. If none appear, search YouTube for Mirvie →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Mirvie.
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]